Kymera Therapeutics (KYMR) Cash & Current Investments (2019 - 2026)
Kymera Therapeutics (KYMR) reported Cash & Current Investments of $690.99 million for Q2 2026, up 3.8% from $665.45 million a year earlier and up 6.2% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics posted Cash & Current Investments of $848.28 million, up 73.6% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 23.4% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $488.74 million in FY2024 (+30.4%), $374.88 million in FY2023 (-7.9%), $407.17 million in FY2022 (-8.0%) and $442.42 million in FY2021 (+49.4%).
- Five-year quarterly Cash & Current Investments spans a low of $357.83 million in Q3 2023 and a high of $848.28 million in Q4 2025.
- Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 26.7% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 82.5%); the low point was Q3 2023 (a decline of 25.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $650.93 million (Q1 2026), $848.28 million (Q4 2025) and $505.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - | 690.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 690.99 Mn |
| Mar 31, 2026 | 650.93 Mn |
| Dec 31, 2025 | 848.28 Mn |
| Sep 30, 2025 | 505.68 Mn |
| Jun 30, 2025 | 665.45 Mn |
| Mar 31, 2025 | 463.15 Mn |
| Dec 31, 2024 | 488.74 Mn |
| Sep 30, 2024 | 549.97 Mn |
| Jun 30, 2024 | 509.95 Mn |
| Mar 31, 2024 | 520.54 Mn |
| Dec 31, 2023 | 374.88 Mn |
| Sep 30, 2023 | 357.83 Mn |
| Jun 30, 2023 | 367.57 Mn |
| Mar 31, 2023 | 396.88 Mn |
| Dec 31, 2022 | 407.17 Mn |
| Sep 30, 2022 | 481.91 Mn |
| Jun 30, 2022 | 392.31 Mn |
| Mar 31, 2022 | 420.81 Mn |
| Dec 31, 2021 | 442.42 Mn |
| Sep 30, 2021 | 536.39 Mn |
API Access
Kymera Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();